In KRAS-mutant colorectal cancer (CRC), de novo cholesterol biosynthesis induced GGPP biosynthesis-dependent proliferation of APC/KRAS-mutant CRCs via the GGPP-KRAS/MEK/ERK axis [99]. The gene discussed is KRAS; the disease is colorectal cancer.